NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGSIf approved, FILSPARI could become the first and ...

Travere Therapeutics' Filspari boosts revenue with FDA approval, but heavy losses and competitive threats raise concerns for ...

The company aims to complete the sNDA submission by the first quarter of 2025, which could potentially lead to Filspari entering the FSGS market by late 2025. In addition, Canaccord Genuity ...

Liverpool’s owners, Fenway Sports Group (FSG), are pressing ahead with plans to add another club to their portfolio. It’s a ...

Liverpool’s owners are now weighing up four of those clubs for purchase, having been deemed the most suitable to join a new ...

Fans Beaten Down to Expect No Purchases Unless Players Sold” written on March 14, 2025 by Jackson Lee. This article is about ...

Sustainability Summary is not assigned to this investment. We sell different types of products and services to both investment professionals and individual investors. These products and services ...

Long-term abuse of anabolic steroids can lead to focal segmental glomerulosclerosis (FSGS), according to a recent study. Although anabolic steroid abuse is known to have adverse effects on the ...

TEAMtalk can reveal Liverpool are stepping up their interest in Dean Huijsen, with the Bournemouth star satisfying three key ...

Her diagnosis of focal segmental glomerulosclerosis (FSGS) would eventually result in kidney failure. Her caregivers laid out a 10-year lifespan if no action were to be taken. Vasquez would soon ...

Travere Therapeutics (TVTX) has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration seeking priority review ...